Z-0083-2023 Class II Ongoing

Recalled by Baxter Healthcare Corporation — Deerfield, IL

FDA device recall Z-0083-2023 was initiated by Baxter Healthcare Corporation on Sep 14, 2022 and is designated Class II. Reason for recall: Within the current Prismaflex set IFU (instructions for use), there is a mistranslation of the Extonian (Eesti) text. The mistranslation indicates contradictory information related to the patient… The recall status is ongoing. Affected quantity: 328,300 devices.

Recall Details

Product Type
Devices
Report Date
Oct 19, 2022
Initiation Date
Sep 14, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
328,300 devices

Product Description

Prismaflex HF Set: HF1000 (product code 107140), HF1400 (product code 107142). For use in providing continuous fluid management and renal replacement therapies.

Reason for Recall

Within the current Prismaflex set IFU (instructions for use), there is a mistranslation of the Extonian (Eesti) text. The mistranslation indicates contradictory information related to the patient body weight restrictions.

Distribution Pattern

US Nationwide

Code Information

UDI 07332414069254 (product code 107140), 07332414069315 (product code 107142); All Lot Codes

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0083-2023
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.